Skip to main content
Top
Published in: Breast Cancer Research 6/2012

01-12-2012 | Erratum

Erratum to: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

Authors: Jisun Kim, Wonshik Han, Hyeong-Gon Moon, Soo K Ahn, Hee-Chul Shin, Jee-Man You, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Hye R Koo, Jung M Chang, Nariya Cho, Woo K Moon, Dong-Young Noh

Published in: Breast Cancer Research | Issue 6/2012

Login to get access

Excerpt

After publication of their article [1], the authors noted an error under the section "Density change and recurrence-free survival". Where it currently reads "After adjusting for confounding factors, patients with MDRR ≥ 15% had a higher risk of recurrence than patients with MDRR <15% (HR 1.60, 95% CI 1.02 to 2.50, P = 0.041) (Additional file 1, Table S5)", this should be changed to "After adjusting for confounding factors, patients with MDRR <15% had a higher risk of recurrence than patients with MDRR ≥ 15% (HR 1.60, 95% CI 1.02 to 2.50, P = 0.041) (Additional file 1, Table S5)." …
Literature
1.
go back to reference Kim J, Han W, Moon HG, Ahn SK, Shin HC, You JM, Han SW, Im SA, Kim TY, Koo HR, Chang JM, Cho N, Moon WK, Noh DY: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Research. 2012, 14: R102-10.1186/bcr3221.CrossRefPubMedPubMedCentral Kim J, Han W, Moon HG, Ahn SK, Shin HC, You JM, Han SW, Im SA, Kim TY, Koo HR, Chang JM, Cho N, Moon WK, Noh DY: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Research. 2012, 14: R102-10.1186/bcr3221.CrossRefPubMedPubMedCentral
Metadata
Title
Erratum to: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
Authors
Jisun Kim
Wonshik Han
Hyeong-Gon Moon
Soo K Ahn
Hee-Chul Shin
Jee-Man You
Sae-Won Han
Seock-Ah Im
Tae-You Kim
Hye R Koo
Jung M Chang
Nariya Cho
Woo K Moon
Dong-Young Noh
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 6/2012
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3353

Other articles of this Issue 6/2012

Breast Cancer Research 6/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine